Showing results (91-100 of 120) with videos related to

Sort By:
Pageof 12
Korean Journal of Clinical Oncology|March 22, 2023
Poorly differentiated thyroid carcinoma: An institutional experienceSeok Won Choi, Joon-Hyop Lee, Yun Young Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2024
Impact of Circulating Tumor Cell-Expressed Prostate-Specific Membrane Antigen and Prostate-Specific Antigen Transcripts in Different Stages of Prostate CancerHyungseok Cho, Seok-Soo Byun, Nak-Hoon Son, et al.
Thyroid : Official Journal of the American Thyroid Association|March 7, 2009
Lateral lymph node metastasis in papillary thyroid carcinoma: results of therapeutic lymph node dissectionYoo Seung Chung, Jee Young Kim, Ja-Seong Bae, et al.
Journal of Clinical Medicine|October 13, 2021
Assessment of Inter-Institutional Post-Operative Hypoparathyroidism Status Using a Common Data ModelJoon-Hyop Lee, Suhyun Kim, Kwangsoo Kim, et al.
European Journal of Cancer (Oxford, England : 1990)|January 11, 2015
Overall survival and renal function after partial and radical nephrectomy among older patients with localised renal cell carcinoma: a propensity-matched multicentre studyJae Seung Chung, Nak Hoon Son, Sang Eun Lee, et al.
World Journal of Surgery|June 15, 2007
Endoscopic thyroidectomy for thyroid malignancies: comparison with conventional open thyroidectomyYoo Seung Chung, Jun-Ho Choe, Kyung-Ho Kang, et al.
Surgery Today|January 24, 2007
The role of surgery after incomplete endoscopic mucosal resection for early gastric cancerYoo Seung Chung, Do-Joong Park, Hyuk-Joon Lee, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 22, 2014
Thulium laser (RevoLix) vaporesection versus vapoenucleation with morcellator (Piranha) for the treatment of benign prostatic obstruction: a propensity-matched multicenter analysisJae Seung Chung, Pil Moon Kang, Won Ik Seo, et al.
Thyroid : Official Journal of the American Thyroid Association|May 17, 2011
Is there a treatment advantage when paclitaxel and lovastatin are combined to dose anaplastic thyroid carcinoma cell lines?Yoo Seung Chung, Sujin Cho, Hee Joo Ryou, et al.
Pageof 12